BRIEF-Redhill Biopharma and Intelgenx submit new drug application to FDA for Rizaport® for migraines
November 01, 2017 at 07:35 AM EDT
* Redhill Biopharma and Intelgenx submit new drug application to FDA for Rizaport® for migraines
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|